Rae, Peter C., Kelly, Richard D. W., Egginton, Stuart and St. John, Justin C.. (2011) Angiogenic potential of endothelial progenitor cells and embryonic stem cells. Vascular Cell, Vol.3 (No.11). ISSN 2045-824X

Preview

PDF WRAP_Kelly_2045-824X-3-11.pdf - Published Version - Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader Download (11Mb)

Abstract

Background: Endothelial progenitor cells (EPCs) are implicated in a range of pathological conditions, suggesting a natural therapeutic role for EPCs in angiogenesis. However, current angiogenic therapies involving EPC transplantation are inefficient due to rejection of donor EPCs. One solution is to derive an expanded population of EPCs from stem cells in vitro, to be re-introduced as a therapeutic transplant. To demonstrate the therapeutic potential of EPCs we performed in vitro transplantation of EPCs into endothelial cell (EC) tubules using a gel-based tubule formation assay. We also described the production of highly angiogenic EPC-comparable cells from pluripotent embryonic stem cells (ESCs) by direct differentiation using EC-conditioned medium (ECCM). Results: The effect on tubule complexity and longevity varied with transplantation quantity: significant effects were observed when tubules were transplanted with a quantity of EPCs equivalent to 50% of the number of ECs originally seeded on to the assay gel but not with 10% EPC transplantation. Gene expression of the endothelial markers VEGFR2, VE-cadherin and CD31, determined by qPCR, also changed dynamically during transplantation. ECCM-treated ESC-derived progenitor cells exhibited angiogenic potential, demonstrated by in vitro tubule formation, and endothelial-specific gene expression equivalent to natural EPCs. Conclusions: We concluded the effect of EPCs is cumulative and beneficial, relying on upregulation of the angiogenic activity of transplanted cells combined with an increase in proliferative cell number to produce significant effects upon transplantation. Furthermore, EPCs derived from ESCs may be developed for use as a rapidly-expandable alternative for angiogenic transplantation therapy.

Item Type:	Journal Article
Subjects:	Q Science > QP Physiology
Divisions:	Faculty of Medicine > Warwick Medical School > Clinical Sciences Research Institute (CSRI) Faculty of Medicine > Warwick Medical School
Library of Congress Subject Headings (LCSH):	Stem cells, Reticulo-endothelial system, Neovascularization
Journal or Publication Title:	Vascular Cell
Publisher:	BioMed Central Ltd.
ISSN:	2045-824X
Date:	11 May 2011
Volume:	Vol.3
Number:	No.11
Identification Number:	10.1186/2045-824X-3-11
Status:	Peer Reviewed
Access rights to Published version:	Open Access
Funder:	Medical Research Council (Great Britain) (MRC)
Grant number:	GO600273 (MRC)
References:	1. Adams RH, Alitalo K: Molecular regulation of angiogenesis and lymphangiogenesis. Nat Rev Mol Cell Biol 2007, 8:464-478. 2. Sirker AA, Astroulakis ZMJ, Hill JM: Vascular progenitor cells and translational research: the role of endothelial and smooth muscle progenitor cells in endogenous arterial remodelling in the adult. Clin Sci 2009, 116:283-299. 3. Risau W: Mechanisms of angiogenesis. Nature 1997, 386:671-674. 4. Paleolog E: It’s all in the blood: circulating endothelial progenitor cells link synovial vascularity with cardiovascular mortality in rheumatoid arthritis? Arthritis Res Ther 2005, 7:270-272. 5. Hudlicka O, Brown M, Egginton S: Angiogenesis in skeletal and cardiac muscle. Physiol Rev 1992, 72:369-417. 6. Shi Q, Rafii S, Wu MH, Wijelath ES, Yu C, Ishida A, Fujita Y, Kothari S, Mohle R, Sauvage LR, Moore MA, Storb RF, Hammond WP: Evidence for circulating bone marrow-derived endothelial cells. Blood 1998, 92:362-367. 7. Burri PH, Djonov V: Intussusceptive angiogenesis–the alternative to capillary sprouting. Mol Aspects Med 2002, 23:S1-27. 8. Hristov M, Weber C: Endothelial progenitor cells: characterization, pathophysiology, and possible clinical relevance. J Cell Mol Med 2004, 8:498-508. 9. Iwami Y, Masuda H, Asahara T: Endothelial progenitor cells: past, state of the art, and future. J Cell Mol Med 2004, 8:488-497. 10. Zhang L, Yang R, Han ZC: Transplantation of umbilical cord bloodderived endothelial progenitor cells: a promising method of therapeutic revascularisation. Eur J Haematol 2006, 76:1-8. 11. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, Witzenbichler B, Schatteman G, Isner JM: Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997, 275:964-967. 12. Michaud SE, Dussault S, Haddad P, Groleau J, Rivard A: Circulating endothelial progenitor cells from healthy smokers exhibit impaired functional activities. Atherosclerosis 2006, 187:423-432. 13. Ding DC, Shyu WC, Lin SZ, Li H: The role of endothelial progenitor cells in ischemic cerebral and heart diseases. Cell Transplant 2007, 16:273-284. 14. Kawamoto A, Asahara T: Role of progenitor endothelial cells in cardiovascular disease and upcoming therapies. Catheterization and cardiovascular interventions: official journal of the Society for Cardiac Angiography & Interventions 2007, 70:477-484. 15. Milkiewicz M, Hudlicka O, Shiner R, Egginton S, Brown MD: Vascular endothelial growth factor mRNA and protein do not change in parallel during non-inflammatory skeletal muscle ischaemia in rat. The Journal of Physiology 2006, 577:671-678. 16. Williams JL, Cartland D, Hussain A, Egginton S: A differential role for nitric oxide in two forms of physiological angiogenesis in mouse. The Journal of Physiology 2006, 570:445-454. 17. Garmy-Susini B, Varner JA: Circulating endothelial progenitor cells. Br J Cancer 2005, 93:855-858. 18. Shantsila E, Watson T, Lip G: Endothelial Progenitor Cells in Cardiovascular Disorders. Journal of the American College of Cardiology 2007, 49:741-752. 19. Heng BC, Liu H, Rufaihah AJ, Cao T: Human embryonic stem cell (hES) colonies display a higher degree of spontaneous differentiation when passaged at lower densities. In Vitro Cell Dev Biol Anim 2006, 42:54-57. 20. Hombach-Klonisch S, Panigrahi S, Rashedi I, Seifert A, Alberti E, Pocar P, Kurpisz M, Schulze-Osthoff K, Mackiewicz A, Los M: Adult stem cells and their trans-differentiation potential-perspectives and therapeutic applications. J Mol Med 2008. 21. Vittet D, Prandini MH, Berthier R, Schweitzer A, Martin-Sisteron H, Uzan G, Dejana E: Embryonic stem cells differentiate in vitro to endothelial cells through successive maturation steps. Blood 1996, 88:3424-3431. 22. Sun X, Cheng L, Duan H, Lu G: Effects of an endothelial cell-conditioned medium on the hematopoietic and endothelial differentiation of embryonic stem cells. Cell Biol Int 2009, 33:1201-1205. 23. Kim GD, Kim GJ, Seok JH, Chung H-M, Chee K-M, Rhee G-S: Differentiation of endothelial cells derived from mouse embryoid bodies: a possible in vitro vasculogenesis model. Toxicology Letters 2008, 180:166-173. 24. Gallagher KA, Liu Z-J, Xiao M, Chen H, Goldstein LJ, Buerk DG, Nedeau A, Thom SR, Velazquez OC: Diabetic impairments in NO-mediated endothelial progenitor cell mobilization and homing are reversed by hyperoxia and SDF-1 alpha. J Clin Invest 2007, 117:1249-1259. 25. Janic B, Guo AM, Iskander ASM, Varma NRS, Scicli AG, Arbab AS: Human cord blood-derived AC133+ progenitor cells preserve endothelial progenitor characteristics after long term in vitro expansion. PLoS ONE 2010, 5:e9173. 26. Kwon S-M, Eguchi M, Wada M, Iwami Y, Hozumi K, Iwaguro H, Masuda H, Kawamoto A, Asahara T: Specific Jagged-1 signal from bone marrow microenvironment is required for endothelial progenitor cell development for neovascularization. Circulation 2008, 118:157-165. 27. Arnaoutova I, George J, Kleinman HK, Benton G: The endothelial cell tube formation assay on basement membrane turns 20: state of the science and the art. Angiogenesis 2009, 12:267-274. 28. Mukai N, Akahori T, Komaki M, Li Q, Kanayasu-Toyoda T, Ishii-Watabe A, Kobayashi A, Yamaguchi T, Abe M, Amagasa T, Morita I: A comparison of the tube forming potentials of early and late endothelial progenitor cells. Exp Cell Res 2008, 314:430-440. 29. Keller GM: In vitro differentiation of embryonic stem cells. Curr Opin Cell Biol 1995, 7:862-869. 30. Boettcher M, Gloe T, de Wit C: Semiautomatic Quantification of Angiogenesis. J Surg Res 2009. 31. Viñals F, Pouysségur J: Confluence of vascular endothelial cells induces cell cycle exit by inhibiting p42/p44 mitogen-activated protein kinase activity. Molecular and Cellular Biology 1999, 19:2763-2772. 32. Grazia Lampugnani M, Zanetti A, Corada M, Takahashi T, Balconi G, Breviario F, Orsenigo F, Cattelino A, Kemler R, Daniel TO, Dejana E: Contact inhibition of VEGF-induced proliferation requires vascular endothelial cadherin, beta-catenin, and the phosphatase DEP-1/CD148. The Journal of Cell Biology 2003, 161:793-804. 33. Ashton AW, Yokota R, John G, Zhao S, Suadicani SO, Spray DC, Ware JA: Inhibition of endothelial cell migration, intercellular communication, and vascular tube formation by thromboxane A(2). J Biol Chem 1999, 274:35562-35570. 34. Dimmeler S, Zeiher AM: Vascular repair by circulating endothelial progenitor cells: the missing link in atherosclerosis? J Mol Med 2004, 82:671-677. 35. Op den Buijs J, Musters M, Verrips T, Post JA, Braam B, van Riel N: Mathematical modeling of vascular endothelial layer maintenance: the role of endothelial cell division, progenitor cell homing, and telomere shortening. Am J Physiol Heart Circ Physiol 2004, 287:H2651-2658. 36. Dimmeler S, Vasa-Nicotera M: Aging of progenitor cells: limitation for regenerative capacity? Journal of the American College of Cardiology 2003, 42:2081-2082. 37. Hattori K, Heissig B, Tashiro K, Honjo T, Tateno M, Shieh JH, Hackett NR, Quitoriano MS, Crystal RG, Rafii S, Moore MA: Plasma elevation of stromal cell-derived factor-1 induces mobilization of mature and immature hematopoietic progenitor and stem cells. Blood 2001, 97:3354-3360. 38. Powell TM, Paul JD, Hill JM, Thompson M, Benjamin M, Rodrigo M, McCoy JP, Read EJ, Khuu HM, Leitman SF, Finkel T, Cannon RO: Granulocyte colony-stimulating factor mobilizes functional endothelial progenitor cells in patients with coronary artery disease. Arterioscler Thromb Vasc Biol 2005, 25:296-301. 39. Breier G, Breviario F, Caveda L, Berthier R, Schnürch H, Gotsch U, Vestweber D, Risau W, Dejana E: Molecular cloning and expression of murine vascular endothelial-cadherin in early stage development of cardiovascular system. Blood 1996, 87:630-641. 40. Zhao H-P, Lu G-X, Wang Q-R: Bone marrow endothelial cell-conditioned medium promotes hematopoietic differentiation of mouse embryonic stem cells. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2003, 11:109-114. 41. Kubo A, Chen V, Kennedy M, Zahradka E, Daley GQ, Keller G: The homeobox gene HEX regulates proliferation and differentiation of hemangioblasts and endothelial cells during ES cell differentiation. Blood 2005, 105:4590-4597. 42. Carlevaro MF, Cermelli S, Cancedda R, Descalzi Cancedda F: Vascular endothelial growth factor (VEGF) in cartilage neovascularization and chondrocyte differentiation: auto-paracrine role during endochondral bone formation. Journal of Cell Science 2000, 113(Pt 1):59-69. 43. Kono T, Kubo H, Shimazu C, Ueda Y, Takahashi M, Yanagi K, Fujita N, Tsuruo T, Wada H, Yamashita JK: Differentiation of lymphatic endothelial cells from embryonic stem cells on OP9 stromal cells. Arteriosclerosis, Thrombosis, and Vascular Biology 2006, 26:2070-2076. 44. Kado M, Lee J-K, Hidaka K, Miwa K, Murohara T, Kasai K, Saga S, Morisaki T, Ueda Y, Kodama I: Paracrine factors of vascular endothelial cells facilitate cardiomyocyte differentiation of mouse embryonic stem cells. Biochemical and Biophysical Research Communications 2008, 377:413-418.
URI:	http://wrap.warwick.ac.uk/id/eprint/35508

Request changes to a record

Actions (login required)

View Item